Weill Cornell study ties neck lymph node removal to cognitive impairment in 18% of younger patients

The Weill Cornell-led study was published in Neuron on September 29 ^[1]. Its clinical arm excluded patients who had radiotherapy or chemotherapy ^[2]. That takes neurotoxic cancer treatment out of the explanation. What is left is a large excess in younger patients. Their rate of impairment is three to four and a half times the expected baseline for their age ^[1]. In patients 65 and older the gap is smaller: 3 percentage points above the top of the expected range ^[2].

The study did not compare these patients with people who had similar cancers and similar operations but kept their nodes. The expected rates come from the general population and from demographic controls ^[3][4]. That comparison cannot separate node removal from the cancer diagnosis, from major surgery itself, or from the closer medical attention that follows an operation. Any of those could raise the number of recorded diagnoses. The published summary also does not say how impairment was identified in the records, what the Munich scans were compared against to call the change accelerated, or how many Munich patients had bilateral surgery.

The Munich cohort gets closer to cause because it compares each patient with themselves. All 59 patients were scanned before and after surgery ^[5]. The atrophy marker changed most after bilateral dissection ^[6]. A bigger effect when more nodes are removed is the dose pattern you would expect if the surgery were the cause. Ventricle size is still not cognition, though, and the imaging and the diagnoses come from different cohorts ^[2][5].

The preclinical results offer a biological route for the association. Blocking cervical drainage produced synapsin clumps unlike amyloid-beta or tau ^[7]. That fits the anatomy mapped over the past decade, in which cerebrospinal fluid and metabolic waste leave the cranial cavity for the deep cervical lymph nodes ^[10]. The protein findings come from preclinical models, and the patient evidence consists of scans and diagnoses ^[2][5][7].

"Your body produces lymphatic fluid to wash away waste from every organ, including the brain," said senior author Laura Santambrogio, a professor of radiation oncology, biochemistry and biophysics at Weill Cornell ^[8][9]. "If this system is lacking, negative consequences may eventually build up." ^[8]

Cervical lymphadenectomy remains a standard, life-saving way to halt the regional spread of head and neck cancers ^[11]. Clinicians already know its peripheral complications, such as neck lymphedema, while its effects inside the skull have had far less attention ^[12]. I think the evidence does not yet support dissecting less. That would take a study that groups patients by how much tissue was removed and follows both cognition and cancer recurrence, because the operation's benefit is measured in cancer control ^[11].